Atlas Trials

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Clinical trial NCT04014803 · RECRUITING

Trial details

NCT number
NCT04014803
Sponsor
Samsung Medical Center
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2020-01-13
Primary completion
2027-06-30
Enrollment
3500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.